Imatinib Mesylate in Treating Patients With Relapsed or Refractory Solid Tumors of Childhood

Clinical trial NCT00030667 · COMPLETED

Trial details

NCT number: NCT00030667
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Childhood Desmoplastic Small Round Cell Tumor Childhood Synovial Sarcoma Gastrointestinal Stromal Tumor Lung Metastases Recurrent Childhood Soft Tissue Sarcoma Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor Recurrent Neuroblastoma Recurrent Osteosarcoma

Start date: 2002-05-01
Primary completion: 2005-12-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.